
    Original Text: Fasting glucose =< 140 mg/dL and glycosylated hemoglobin measurement (HbA1c) =< 7%
    Disease/Condition: Diabetes Mellitus Type II
    Procedure: none
    Drug: none
    Biomarker: HbA1c < 7%
    Computable Rule: Disease is "Diabetes Mellitus Type II" AND HbA1c < 7% is True

Criterion:
    Patients with metastatic colorectal cancer who have received prior treatment with oxaliplatin, irinotecan, fluoropyrimidine, and anti-VEGF therapy

Output:
    Original Text: Patients with metastatic colorectal cancer who have received prior treatment with oxaliplatin, irinotecan, fluoropyrimidine, and anti-VEGF therapy
    Disease/Condition: Metastatic Colorectal Cancer
    Procedure: none
    Drug: none
   